YOU ARE HERE: LAT HomeCollectionsBlood Cells

Blood Cells

January 7, 1997 | LEO SMITH
A drug manufactured by Amgen of Thousand Oaks to aid the production of red blood cells has received approval from the federal Food and Drug Administration to be used prior to surgery. The drug, Procrit, is marketed by Ortho Biotech Inc., a unit of New Jersey-based Johnson & Johnson. Procrit is a genetically engineered version of a natural human hormone, erythropoietin, which stimulates bone marrow to produce red blood cells.
October 14, 1991 | From Times Staff and Wire Reports
For the first time, researchers have diagnosed fetal genetic disorders by taking blood samples from pregnant women, eliminating risk to the fetus. The new techniques rely on the fact that a very small number of fetal blood cells can make their way into a pregnant woman's bloodstream through leaks in the placenta. The cells are very rare in the mother's bloodstream, however.
November 2, 1986 | --Compiled from Times staff and wire service reports
A virus may be the cause of Kawasaki syndrome, a mysterious disease that causes life-threatening heart abnormalities in children and is especially prevalent among youngsters of Japanese and Korean descent, according to Harvard Medical School researchers. In studies on the white blood cells of Kawasaki syndrome patients, the researchers have detected a key viral enzyme, called reverse transcriptase, which is normally not present in blood cells.
September 14, 1998
During this period, the structure of the fetus is completed to the extent that major abnormalities--or good health-- can be determined. MONTH FOUR Weeks 15-16: Amniocentesis can be performed to check for birth defects MONTH FIVE Weeks 16-18: Substantial cardiac defects can be determined. The fetus is fully formed, about 5 inches long. Fetal heart beats twice as fast as mother's. Weeks 18-20: Stem cells begin to occupy the fetal bone marrow. Fetus begins to move.
February 2, 2012 | By Anna Gorman, Los Angeles Times
Christina Blouvan-Cervantes had been battling aggressive leukemia when her blood count plummeted and she landed in the emergency room in Fresno. Her doctors told her a blood transfusion was her only hope. But her faith wouldn't allow her to receive one. So she turned to one of the only doctors who could possibly keep her alive: a committed atheist who views her belief system as wholly irrational. Dr. Michael Lill, head of the blood and marrow transplant program at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute, is a last recourse for Jehovah's Witnesses with advanced leukemia.
September 3, 1987 | HARRY NELSON, Times Medical Writer
A genetically engineered hormone with the potential for revolutionizing the treatment of infections has passed its first human safety trial, UCLA and Harvard medical scientists said in a report published today. In experiments conducted in Los Angeles and Boston, the hormone was given to 16 AIDS patients suffering from a wide variety of viral, bacterial and fungal infections that typically afflict people with acquired immune deficiency syndrome.
July 8, 1986 | BARRY S. SURMAN, Times Staff Writer
Tori Lee Glezos, the first patient to receive a bone-marrow transplant at an Orange County hospital, is ill with an infection and pneumonia, but her spirits are high, and her doctors say they believe that her chances for survival are still strong. Doctors at Childrens Hospital of Orange County had predicted that 9-year-old Tori would suffer some kind of infection before the transplanted marrow took root and began producing disease-fighting white blood cells.
December 16, 2011 | By Jeannine Stein, Los Angeles Times / For the Booster Shots blog
News came today that singer Etta James is terminally ill with chronic leukemia; the Riverside Press-Enterprise also reports that the 73-year-old is suffering from kidney failure and dementia. Leukemia is a cancer of the blood and bone marrow, where blood cells are produced. When abnormal cells are created they disrupt the function of healthy cells. The disease can be acute or chronic; in acute leukemia, common in children, immature or early blood cells multiply quickly, and immediate treatment is usually necessary.
Los Angeles Times Articles